Alto Neuroscience, Inc. (ANRO)

NYSE HEALTHCARE
$24.30 -0.69% RSI 52 Neutral Add Alert

Moving Averages

SMA 200
$11.57
Price above

Company Profile

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$727.72M
P/E Ratio
None
EPS
$-2.19
Beta
2.059
Dividend Yield
0.00%
52-Week High
$25.17
52-Week Low
$2.02

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 45.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0

Data last updated: April 11, 2026 at 8:41 AM EDT

Track ANRO for free

Get e-mail RSI alerts when Alto Neuroscience, Inc. enters oversold or overbought territory. Free forever.

Add Alert